Search
for
Sort by
Research 241–270 of 550
- Understanding Anxiety and Knowledge Gaps Surrounding Laser Hair Removal: A Clinic-Based Cross-Sectional Study
- Effects of Methionine Supplementation in Low-Protein Diets on Growth Performance, Fur Quality, Blood Indices, and Intestinal Microbiota of Blue Foxes (Vulpes lagopus) During the Fur-Growing Period
- A narrative review of SARS-CoV-2 variants and long COVID
- A systematic review and meta‐synthesis of qualitative studies of alopecia: Managing identity and appearance changes
- First clinical cases of leishmaniosis in meerkats (Suricata suricatta) housed in wildlife parks in Madrid, Spain
- Celiac Disease: Beyond Diet and Food Awareness
- Hormonal Therapies for Acne: A Comprehensive Update for Dermatologists
- Evaluating changes in the breast cancer-related quality of life of young women with breast cancer: long-term results from a multicenter prospective cohort
- Wigs and Alopecia Areata: Psychosocial Impact and Economic Considerations
- Developing criteria for a profession to be considered as profession of allied health in Malaysia: a qualitative study from the Malaysian perspective
- Cutaneous Manifestations in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy (APECED): A Comprehensive Review
- Sdr16c5 and Sdr16c6 control a dormant pathway at a bifurcation point between meibogenesis and sebogenesis
- Developing recommendations for promoting wellbeing in individuals with alopecia areata: a modified Delphi study
- Risk factors and comorbidities associated with central centrifugal cicatricial alopecia
- Cardiovascular Safety Signals of Oral Versus Topical Minoxidil in FAERS: A Disproportionality Analysis (Analytic Cohort 2012–2025)
- A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Postfinasteride Syndrome
- Re: A Review of the FAERS Data on 5-Alpha Reductase Inhibitors: Implications for Post-Finasteride Syndrome
- Adverse events with finasteride or dutasteride: FAERS
- Assessing the safety of topical minoxidil through disproportionality analysis of FAERS reports
- 0917 Finasteride is Associated with a Higher Odds of Obstructive Sleep Apnea (OSA): Results from the US FDA Adverse Events Reporting System (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Evaluating the safety profile of α-1 blockers, 5α-reductase inhibitors, and PDE5I for BPH: a disproportionality analysis of real-world adverse events based on FDA adverse event reporting system (FAERS)
- Assessing dutasteride-associated sexual dysfunction using the U.S. Food and Drug Administration Adverse Event Reporting System
- A cross‐sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system
- 0439 Temporal–phenotype signatures of alopecia associated with GLP-1–based therapies: A PRISMA-ScR scoping review
- Correction to: An evaluation of the federal adverse events reporting system data on adverse effects of 5‑alpha reductase inhibitors
- MP89-08 POST-FINASTERIDE SYNDROME: REAL OR IMAGINED?
- Hair Cuts Cause Cancer
- Multimodal Recruitment to Study Ovulation and Menstruation Health: Internet-Based Survey Pilot Study (Preprint)
- Improved Transgender Care in the ED